Christina Engstrand1, Barbro Krevers2, Göran Nylander2, Joanna Kvist2. 1. Department of Hand Surgery, Plastic Surgery and Burns, County Council of Östergötland; Division of Physiotherapy, and Division of Health Care Analysis, Department of Medical and Health Sciences, Linköping University; Linköping, Sweden. Electronic address: christina.engstrand@lio.se. 2. Department of Hand Surgery, Plastic Surgery and Burns, County Council of Östergötland; Division of Physiotherapy, and Division of Health Care Analysis, Department of Medical and Health Sciences, Linköping University; Linköping, Sweden.
Abstract
PURPOSE: To describe changes in joint motion, sensibility, and scar pliability and to investigate the patients' expectations, self-reported recovery, and satisfaction with hand function, disability, and quality of life after surgery and hand therapy for Dupuytren disease. METHODS: This prospective cohort study collected measurements before surgery and 3, 6, and 12 months after surgery and hand therapy. Ninety patients with total active extension deficits of 60° or more from Dupuytren contracture were included. Outcomes measures were range of motion; sensibility; scar pliability; self-reported outcomes on expectations, recovery, and satisfaction with hand function; Disabilities of the Arm, Shoulder, and Hand scores; safety and social issues of hand function; physical activity habits; and quality of life with the Euroqol. RESULTS: The extension deficit decreased, and there was a transient decrease in active finger flexion during the first year after surgery. Sensibility remained unaffected. Generally, patients with surgery on multiple fingers had worse scar pliability. The majority of the patients had their expectations met, and at 6 months, 32% considered hand function as fully recovered, and 73% were satisfied with their hand function. Fear of hurting the hand and worry about not trusting the hand function were of greatest concern among safety and social issues. The Disability of the Arm, Shoulder, and Hand score and the Euroqol improved over time. CONCLUSIONS: After surgery and hand therapy, disability decreased independent of single or multiple operated fingers. The total active finger extension improved enough for the patients to reach a functional range of motion despite an impairment of active finger flexion still present 12 months after treatment. TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic IV.
PURPOSE: To describe changes in joint motion, sensibility, and scar pliability and to investigate the patients' expectations, self-reported recovery, and satisfaction with hand function, disability, and quality of life after surgery and hand therapy for Dupuytren disease. METHODS: This prospective cohort study collected measurements before surgery and 3, 6, and 12 months after surgery and hand therapy. Ninety patients with total active extension deficits of 60° or more from Dupuytren contracture were included. Outcomes measures were range of motion; sensibility; scar pliability; self-reported outcomes on expectations, recovery, and satisfaction with hand function; Disabilities of the Arm, Shoulder, and Hand scores; safety and social issues of hand function; physical activity habits; and quality of life with the Euroqol. RESULTS: The extension deficit decreased, and there was a transient decrease in active finger flexion during the first year after surgery. Sensibility remained unaffected. Generally, patients with surgery on multiple fingers had worse scar pliability. The majority of the patients had their expectations met, and at 6 months, 32% considered hand function as fully recovered, and 73% were satisfied with their hand function. Fear of hurting the hand and worry about not trusting the hand function were of greatest concern among safety and social issues. The Disability of the Arm, Shoulder, and Hand score and the Euroqol improved over time. CONCLUSIONS: After surgery and hand therapy, disability decreased independent of single or multiple operated fingers. The total active finger extension improved enough for the patients to reach a functional range of motion despite an impairment of active finger flexion still present 12 months after treatment. TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic IV.
Authors: Takashi Hirase; Rishi Suresh; Michael O Cotton; Alex Han; Matthew B Burn; Joshua D Harris; Shari R Liberman Journal: J Hand Microsurg Date: 2020-12-31
Authors: Anouk M Oosterwijk; Marianne K Nieuwenhuis; Hennie J Schouten; Cees P van der Schans; Leonora J Mouton Journal: PLoS One Date: 2018-08-01 Impact factor: 3.240
Authors: Rafael Sanjuan-Cervero; Diego Gomez-Herrero; Pedro Vazquez-Ferreiro; Aurora Sanjuan-Arago; Jaime E Poquet-Jornet; Javier Carrer-Hueso Journal: Cureus Date: 2022-01-26
Authors: Chao Zhou; Steven E R Hovius; Adriana J Pieters; Harm P Slijper; Reinier Feitz; Ruud W Selles Journal: Plast Reconstr Surg Glob Open Date: 2017-09-25